{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-049371","form_type":"8-K","ticker":"PRPO","cik":"0001043961","company_name":"Precipio, Inc.","filed_at":"2025-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.291633+00:00","generated_at":"2026-05-21T04:22:27.615847+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Precipio Q1 revenue up 43% to $4.9M; adjusted EBITDA loss narrows 92% to $108K","bullets":["Revenue $4.9M, +43% YoY; overall gross margin improved to 43% from 27%.","Adjusted EBITDA loss of $108K vs $1.41M loss YoY, a 92% improvement.","Cash used in operations was $44K vs $667K, improvement of 93%.","Pathology Services rev +54%, test volume +46%; Products division onboarded 1 new customer, launched 2 panels.","CEO expects positive operating cash flow in Q2 or Q3; Q2 received ~$400K CARES Act credit."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-049371","json":"https://secwatch.observer/filing/0001104659-25-049371.json","markdown":"https://secwatch.observer/filing/0001104659-25-049371.md","text":"https://secwatch.observer/filing/0001104659-25-049371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1043961/000110465925049371/0001104659-25-049371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1043961/000110465925049371/tm2515302d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T04:22:27.615847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}